Pridax
Replacement
|
Medicines
|
30/05/2011
The marketing authorization holder informed its supplied customers in a letter dated May 26, 2011, that the degradation product prostaglandin A1 (PGA1) was above the specified limit at the end of the 24-month period and thus a replacement had to be carried out.
| Name of the medicinal product | Pridax 20 Mikrogramm/ml - Konzentrat zur Herstellung einer Infusionslösung |
|---|---|
| Marketing authorisation number(s) | 1-22020 |
| Marketing authorisation holder | Gebro Pharma GmbH |
| Batch number(s) | 20 Chargen: 9326022AT, 9446011AT, 9476081AT, 9536011AT, 1001021AT, 1004013AT, 1004062AT, 1006071AT, 1009012AT, 1009061AT, 1017091AT, 1024102AT, 1026011AT, 1026041AT, 1027071AT, 1036022AT, 1047061AT, 1052042AT, 042103, 043103 |
| Classification of the recall | 2 |
| BASG reference number | INS-640.001-0141 |
Further inquiry note
Page last modified:
12/07/2022